Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Luveltamab Tazevibulin in Acute Myeloid Leukemia: NCT06679582 Clinical Landscape Report 2026
16 October 2026
NCT06679582 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Lenalidomide in Multiple Myeloma: NCT06679101 Clinical Landscape Report 2026
16 October 2026
NCT06679101 clinical landscape for Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Telitacicept in Systemic Lupus Erythematosus: NCT06677801 Clinical Landscape Report 2026
16 October 2026
NCT06677801 clinical landscape for Systemic Lupus Erythematosus: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Mesna in Demyelinating Autoimmune Diseases, CNS: NCT06677710 Clinical Landscape Report 2026
16 October 2026
NCT06677710 clinical landscape for Demyelinating Autoimmune Diseases, CNS: endpoints, sponsor, phase, geography, readouts, asset context and development whit…
9 min read
BRL-303 in Lupus Nephritis: NCT06681337 Clinical Landscape Report 2026
16 October 2026
NCT06681337 clinical landscape for Lupus Nephritis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Fludarabine Phosphate in Relapsing acute myeloid leukemia: NCT06680752 Clinical Landscape Report 2026
16 October 2026
NCT06680752 clinical landscape for Relapsing acute myeloid leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
9 min read
Fludarabine Phosphate in Hodgkin's Lymphoma: NCT06680661 Clinical Landscape Report 2026
16 October 2026
NCT06680661 clinical landscape for Hodgkin's Lymphoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Melphalan in Multiple Myeloma: NCT06679829 Clinical Landscape Report 2026
16 October 2026
NCT06679829 clinical landscape for Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
CD19-CAR_Lenti_ALLO in Churg-Strauss Syndrome: NCT06685042 Clinical Landscape Report 2026
16 October 2026
NCT06685042 clinical landscape for Churg-Strauss Syndrome: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Atorvastatin Calcium in Acute Myeloid Leukemia: NCT06684509 Clinical Landscape Report 2026
16 October 2026
NCT06684509 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Autologous CD19 CAR-T(Hematology Hospital of Chinese Academy of Medical Sciences) in Idiopathic Inflammatory Myopathies: NCT06680388 Clinical Landscape Report 2026
16 October 2026
NCT06680388 clinical landscape for Idiopathic Inflammatory Myopathies: endpoints, sponsor, phase, geography, readouts, asset context and development white sp…
9 min read
Nivolumab in Muscle Invasive Bladder Urothelial Carcinoma: NCT06682728 Clinical Landscape Report 2026
16 October 2026
NCT06682728 clinical landscape for Muscle Invasive Bladder Urothelial Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and developmen…